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Abstract
Platform organizations bring renewed attention to power disparities and risks in the rise of surveillance capitalism. However, such critical
accounts provide a partial understanding of the complexity of surveillance phenomena in such shifting socio-technical and digital environments.The findings from a netnographic investigation of a healthcare platform organization, PatientsLikeMe, unravel how platforms become
the locus where multi-level flows of surveillance converge, thereby constituting what we identify as a surveillant assemblage. We develop a
comprehensive approach for understanding how platforms constitute a dynamic crossroads of micro-, meso- and macro-surveillance phenomena within and beyond the online communities they create. This study highlights this surveillant assemblage’s emerging practices and
potentially empowering outcomes that enable multi-stakeholder involvement in big data and knowledge generation in healthcare. Broader
implications of multi-level surveillance in and through platforms are discussed.
Keywords: Multi-level surveillance; Surveillant assemblage; Platform organization; Netnography; Healthcare
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ass datafication in the rise of platform organizations has
renewed legitimate concerns regarding surveillance phenomena owing to the platform’s overwhelming algorithmic data-extraction power. Beyond anything in Orwell’s (1949)
dystopian imagination or Foucault’s (1979) descriptions of disciplinary institutions, surveillance in platforms seems ubiquitous
(Andrejevic, 2012) and ever more complex today (Farinosi, 2011).
As spatially delimited digital infrastructures bringing together a
network of stakeholders, platforms are reconfiguring socio-economic ecosystems (Orlikowski & Scott, 2014), combining
self-quantification with community dynamics and market relations
(Chanal & Caron-Fasan, 2010) to produce new or challenge existing forms of organization, provision of services and wealth creation (Srnicek, 2016). Through their ‘data mining capabilities of
discovering meaningful patterns and distilling them into predictive
analytics’ (Cohen, 2013, p. 1920), they are ‘shaping and computing
the everyday’ (Alaimo & Kallinikos, 2017). Among other things, on
platforms, people are massively, continuously, knowingly (or not),
and willingly (or reluctantly) being surveilled for a profit (Fuchs,
2011; Zuboff, 2019). This brings renewed questions concerning

how surveillance functions and what outcomes it yields in and
through platforms where diverse human or nonhuman stakeholders participate in the production, distribution, monitoring, and
usage of information at an unprecedented scale.
While scholarly attention has overly focused on critical accounts,
the way surveillance actually functions in such shifting socio-technical environments as platforms remains an understudied and complex issue. One such platform captured our attention:
PatientsLikeMe, a for-profit ad-free healthcare platform harboring
several disease-specific online communities. Our extensive netnographic study of PatientsLikeMe suggests that it is more than extracting and selling health data from surveilling its online community.
Both in and through the platform, various levels of surveillance
mechanisms were at play, yielding outcomes other than coercive
control and exploitation. These included a series of relational and
learning mechanisms for patients to care for each other while increasing their own disease literacy and empowerment (micro),
changing patient–healthcare provider relationships via personalized
medicine and normalizing data sharing in and beyond the platform
(meso), and shifting power hierarchies in healthcare and medical
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knowledge generation through connecting multiple stakeholders,
tools, and practices (macro).
Such findings problematize the theoretical and ideological
assumptions (Alvesson & Sandberg, 2011) that dominate surveillance regarding platforms, seen predominantly as a macro-level phenomenon aimed at control and profit. Indeed,
some scholars have noted how surveillance can be as much
about controlling as about caring (e.g., Lyon, 2006; Iedema &
Rhodes, 2010; Sewell & Barker, 2006), highlighting a tension at
the crossroads of multiple levels and outcomes of surveillance
that warrant further attention. This leads us to argue that in
overly focusing on the – important, yet not sole – issue of
power disparities, control and profit-making, other dynamics
and outcomes of surveillance in platforms have been both neglected and easily dismissed as either naïve or as the product
of the ideological apparatus sustained by platform giants. What
has been particularly overlooked is to address in greater depth
the multi-level complexity of surveillance practices in and
through platforms and their outcomes, which is the objective
of this research study. Our study findings unpack the dynamics
of surveillance flows constituting multi-level sociomaterial interactions involving and affecting diverse human or nonhuman
stakeholders, including PatientsLikeMe community, healthcare
providers, pharmaceuticals, governmental bodies, research institutions, tracking tools and algorithms, and data-tracking and
aggregation processes. In studying how such multi-level surveillance flows were intricately woven together on PatientsLikeMe,
we bring forward two main contributions.
First, we draw attention to how surveillance functions in and
through platforms, which constitute a dynamic crossroad of
micro-, meso-, and macro-surveillance phenomena both within
their online communities and beyond. This led us to understand platforms as digitally mediated spaces for surveillance,
that is, as loci where multi-level surveillance phenomena converge, thereby constituting a surveillant assemblage, a term
coined by Haggerty and Ericson (2000) which has revitalized
studies of contemporary surveillance (Galič et al., 2017).
Drawing selectively on Deleuzian (Deleuze, 1990; Deleuze &
Guattari, 1980) analysis of surveillance transformations in the
digital age, they apply the notion of assemblages to surveillance
studies to theorize the multiple objects in flow (information,
bodies, desires, institutions, and processes) that make several
systems of surveillance converge into a functional entity that
transforms the purposes and hierarchies of surveillance.
Second, we answer calls to explore surveillance’s outcomes
other than discipline, control, and capitalistic exploitation, seeking to explore its potentially productive (Lyon, 2007), participatory (Albrechtslund, 2008), collaborative (Pridmore, 2013),
or even existential (Hafermalz, 2020) outcomes. In our case, in
becoming a new pole where flows of information, actors, and
surveillance practices converge, that is, in constituting a surveillant assemblage, PatientsLikeMe fosters an empowering
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potential of surveillance in healthcare, drawing attention to
enabling and constraining power dynamics on healthcare
platforms.
We begin by reviewing the literature on platforms and surveillance to point out some limitations and neglected aspects.
We then present our case and netnographic method, followed
by our findings that allow us to understand surveillance in platforms as a multi-level surveillant assemblage. Finally, we discuss
implications and contributions, and outline some potentials
and pitfalls for future research as concluding remarks.

Platforms and surveillance
Surveillance capitalism and its risks
Platforms, as dominant organizational forms, today are ‘data-based organizations that extract value and make profit from
the social everyday they themselves engineer’ (Alaimo &
Kallinikos, 2017, p. 176). As put by Fuchs (2011, p. 289), ‘the
discussion of surveillance in web 2.0 is important because such
platforms collect huge amounts of personal data in order to
work’, that is, by commodifying every digital trace of those
surveilled (Lyon, 2001, 2002; West, 2019). As surveillance is ‘a
technology-dependent concept’ (Galič et al., 2017, p. 26), how
surveillance unfolds in such specific socio-technical and organizational environments is inescapably linked to the fact that they
have become mastodons of wealth creation (Srnicek, 2016).
Although links between surveillance and capitalism go much
further back than today’s Internet giants, such as Google and
Facebook (Foster & McChesney, 2014; Fuchs, 2011), the commodification capacities of platforms’ infrastructure for extracting data asymmetrically, without dialogue or consent (Galič et
al., 2017) have brought renewed concerns for ‘surveillance
capitalism’ that relies on surveillance as its key modus operandi,
which ‘tunes’ and ‘herds’ (Zuboff, 2019, pp. 294–295) our online behaviors into commoditized assets.
Such production of information becomes the source of data-driven and algorithmically commercialized instrumentarian
power that Zuboff (2015, p. 75) christens ‘‘Big Other’ (…) that
effectively exile(s) persons from their own behavior while producing new markets of behavioral prediction and modification’.
Furthermore, such transformations in information accumulation rely on compatible legal structures that paradoxically enable it by considering the data extracted to be ‘raw’ data, that
is, being in the ‘public domain’, available for taking (Cohen,
2018). This has fostered numerous preoccupations about how
it secures government collusion, and about the strength of its
ideological and narrative justifications, including the free and
open network, instant and customized personalization, and
new forms of consumer power. However, the ‘sharing’ economy has been shown to not always deliver on the promise of
social connection, and instead, harbors labor exploitation,
19
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discrimination, and inequality, as well as power asymmetries,
algorithmic biases and discriminations, tailored advertising, and
invasion of privacy (e.g., Gillespie, 2017; Schor & AttwoodCharles, 2017; Visser et al., 2019; West, 2019). Reversely, the
concept of privacy – which is defined as freedom from and
resistance to surveillance (Farinosi, 2011; Lyon, 2001;
Solove, 2002) – is also sustained by strong and equally contestable ideologies, and often obscure power dynamics that play
out in eminently complex ways in platforms.

The complexity and ambivalence of surveillance
Economic dominance of platforms today makes considerations
of surveillance in this context to almost exclusively ‘emphasize
how they cumulatively pose a threat to civil liberties’ (Haggerty
& Ericson, 2000, p. 610), leading numerous relevant issues on
surveillance in platforms to be neglected, easily dismissed, or
deprioritized. These concerns nevertheless reflect only a partial picture, given the complexity of how surveillance works in
and through platforms. As big data are both ‘a powerful tool to
address various societal ills, offering the potential of new insights into areas as diverse as cancer research, terrorism, and
climate change [… and] a troubling manifestation of Big
Brother, enabling invasions of privacy, decreased civil freedoms,
and increased state and corporate control’ (Boyd & Crawford,
2012, p. 664), some studies encourage us to not completely
downplay the productive potentialities of surveillance in favor
of its risks.
Owing to this inherent ambivalence, surveillance studies
tend to neglect potential positive developments of surveillance
practices (e.g., in science and medicine, relevant to our empirical case) (Galič et al., 2017). In unpacking this ambivalence, we
remark that most of the dark claims operate at a macro-economic level, and that more in-depth studies of how specific
organizational forms, such as platforms, participate in surveillance (whether capitalistic) are insufficiently developed. This is
surprising, particularly considering that surveillance studies
have always been sensitive to the organizational, material, and
technological dimensions that make surveillance possible, at
least since Bentham’s seminal work on the Panopticon and
architecture-based conceptions of surveillance (Galič et al.,
2017), which have over-stretched this metaphor (Brivot &
Gendron, 2011; De la Robertie & Lebrument, 2019; Hafermalz,
2020; Haggerty, 2006). However, in ‘going beyond’ the
Panopticon, paying attention to the organizational architecture,
the infrastructure and the technological materiality of surveillance need not be forgotten.
Without denying the risks, other outcomes besides control
and exploitation are worth noticing, with leading scholars in surveillance studies continuously stressing the ambivalence of surveillance as being simultaneously about controlling and caring
(Haggerty & Ericson, 2000; Lyon, 2001, 2006, 2014).This yields a
20

bilateral tension between surveillance’s coercive (supervision
and subordination) and caring (protection from deviance) roles
(Sewell & Barker, 2006). For instance, studies on self-surveillance
and organizational surveillance (Iedema & Rhodes, 2010; Vaz &
Bruno, 2003) have shown how power and care are actually very
difficult to separate. This might explain why researchers have
overlooked caring surveillance in favor of more obvious issues of
domination and often disguised control (Weiss, 2005). Binary
conceptualizations of surveillance – for example, coercive caring
and passive resistant (Iedema & Rhodes, 2010; Sewell & Barker,
2006) – tend to provide a polarized and therefore limited picture, leaving much unchartered territory in emerging surveillance phenomena (Albrechtslund, 2008; Pridmore, 2013),
particularly in the digital environments.
Scholars developed the concepts of reverse surveillance
(Brin, 1998) and sousveillance (Mann et al., 2003) to draw attention to the disciplinary effect exerted by the bottom-up
movement to counter the top-down scrutiny by the corporate
elite. Being watched (e.g., followed on social media) is also an
asset (Lyon, 2007) fulfilling exhibitionist and narcissistic desires
(Koskela, 2004), while making surveillance playful and entertaining (Albrechtslund & Dubbeld, 2005). Voluntary visibilization practices through surveillance technologies can even be a
matter of ‘existential recognition’ of belonging (Hafermalz,
2020). Consequently, considering surveillance as a potentially
empowering (Albrechtslund, 2008; Haggerty & Ericson, 2000)
and a productive practice (Lyon, 2007) warrants further attention, as it is a controversial, counter-intuitive issue.
Consequently, we aim to uncover how surveillance plays
out at various levels that platforms operate within, shifting relations and directions of visibility mediated by various technologies. Platforms become a privileged site to study the
transformations of the surveillant gaze, as they increasingly blur
the differences between agents and targets of surveillance and
mitigate power relations (Galič et al., 2017). In platforms, surveillance technologies are more than an ‘electronic panopticon’
(Lyon, 1994) that imposes a centralized gaze (usually by the
State or the corporation) on passive others (citizens, employees or consumers). They simultaneously foster lateral surveillance (Brivot & Gendron, 2011), self-surveillance (Albrechtslund,
2008; Vaz & Bruno, 2003), among other variants where the increased visibility between a surveyor and surveilled make
them more active in this process (Farinosi, 2011). Following
Hafermalz (2020, p. 7, quoting Han 2015), it is worth asking
what happens when ‘the inhabitants of the digital panopticon
[…] are engaged in ‘lively communication’ and actively produce
and share personal information and ‘bare’ themselves to one
another ‘of their own free will?’’ Reviewing the literature on the
notion of surveillant assemblages, the next section adds the
theoretical missing piece for uncovering this complex and dynamic context, inclusive of some of the neglected aspects and
ambivalent tensions detailed above.
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Surveillant assemblages: Studying surveillance in
the digital context
In a recent review, Galič and colleagues (2017) provide a tripartite chronological–thematic overview of surveillance studies and locate Zuboff ’s development of surveillance capitalism
within the second phase of post-panoptic or ‘infrastructural
theories’. However, we are interested in the other two approaches included in this phase: Deleuze’s (1990) analysis of
control societies (Deleuze & Guattari, 1980) and its reinterpretation by Haggerty and Ericson (2000) to conceptualize
the notion of surveillant assemblage. What makes this phase
particularly interesting is that it signals the move from physical
materiality (e.g., the prison with its central tower) to digital
materiality (e.g., algorithms and connected devices), on the
one side, and from a (relatively) single direction of explicit gazing to a networked, decentralized, and often invisible gazing, on
the other. Furthermore, the goal of surveillance is no longer
discipline, but control, as it is no longer institutions but corporations that orchestrate surveillance. This shifts the temporality
of surveillance from a potentially omnipresent gaze on individuals to an effective omnipresent recording of what Deleuze calls
dividuals, that is, the fragmented divided individual, whose variety can be recorded and stored in many different data banks in
the rise of digital technologies for consumerist purposes.
Building selectively on this Deleuzian heritage that we have
very succinctly summarized, Haggerty and Ericson (2000,
p. 606) noted that we are ‘witnessing a convergence of what
were once discrete surveillance systems to the point that we
can now speak of an emerging ‘surveillant assemblage.’ ’ They
argue that this can better account for technological transformations, the move from a human gaze to machine-based
tracking in a rhizomatic and networked expansion, and a certain leveling of hierarchies (later developed and nuanced by
Haggerty, 2006). An assemblage is a ‘functional entity’ grouping
heterogeneous objects in flow (including people, institutions,
processes, algorithms, information…) that ‘work’ together,
serving a surveillance purpose of generating data and knowledge through monitoring of ongoing interaction between
these objects (Delanda, 2016). Assemblages are a ‘potentiality’:
their apparent stability conceals in fact a multiplicity of flows in
temporarily more or less fixed arrangements, each, in turn,
composed of multiple discrete assemblages. A range of desires
– understood as immanent, active and positive forces, including
desires for control, governance, security, profit and entertainment – hold the assemblage together (Haggerty & Ericson,
2000, p. 609). Surveillant assemblages ‘can hence be seen as
‘recording machines,’ as their task is to capture flows and convert them into reproducible events’ (Galič et al., 2017, p. 21),
particularly now with computerized datafication, as ‘centres of
appropriation where these flows can be captured’ (Haggerty &
Ericson, 2000, p. 608).
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Humans here, work alongside technology in a ‘multi-agency’
constitution of assemblages, and human bodies are understood as hybrid compositions, flesh-technology-information
amalgams, broken down into dividuals or ‘data doubles’ (e.g.,
consumer profiles), which are then re-assembled (e.g., consumption patterns). Before they can be controlled, molded, or
punished, bodies must be known by ‘centres of calculation’,
such as statistical institutions, the police or laboratories that
open or close access to information, for the people behind
such ‘data doubles’. At the interface of de-corporealized measurable bodies and technologies, surveillance reduces flesh
(but also non-human bodies) to information, turning them into
a renewed form of ‘surplus value’. Previously scattered records
are digitally combined to serve new purposes, such as marketing, policing, and entertainment (Haggerty, 2006). Combinations
are triggered and intensified ‘when there is some perceived ex
post facto or prospective need’ (Haggerty & Ericson, 2000,
p. 618), and are therefore potentially infinite.
In sum, the surveillant assemblage ‘can be seen as the first
recognition that surveillance needs to be analyzed in context’
(Galič et al., 2017, p. 34), as we shall do through our empirical
case discussed next. Seeking to understand the complexity of
how surveillance functions in and through platforms in these
terms, we ask how do multi-level flows, directions, agents, and
targets of surveillance interact on platforms and with which
outcomes?

Studying surveillance in a healthcare platform
organization
Relevance of the healthcare sector
Control over knowledge about the body but also the conditions of discourse on this knowledge (e.g., the ‘truth’ about
disease) has traditionally been the object of one-way scrutiny
by ‘sages’ (e.g., the medieval clergy, the rational ‘medical gaze’),
as shown by Foucault’s (1975) genealogy of the clinic. As such,
each system of truth prevents collaboration and contestation
of the conditions, as well as of the content of the discourse by
actors other than its main gatekeepers (clergy, then doctors),
and first and foremost by patients themselves.To date, patients
usually do not have an inherent right to their data that healthcare providers hold, as medical data flow predominantly to
experts.
This power asymmetry rooted in control of expert information operates at various levels. At the macro-level of policies (cf. Fotaki, 2009), governments and healthcare providers
set boundaries on the distribution of patient health records to
third parties with the excuse of protecting patient privacy, and
large pharmaceutical companies promote health ideologies
structured around their products (such as vaccinology) (Picard
et al., 2017), two sensitive issues that the COVID-19 pandemic
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has recently revamped. At the micro-level, consumerist approaches to healthcare reinforce the myth of patient choice and
promote ‘prosumption’ as a means to exploit patients (by making
them produce the service they need, in making them responsible
for managing their diseases), thereby increasing patients’ vulnerability and inequality in terms of access to care, particularly when
it depends on and is mediated by supposedly ‘neutral’ technologies that gloss over patients’ differences (Visser et al., 2019).
However, albeit being intertwined, access to healthcare and
access to health information are two different things. While the
consumerist approach focuses on the former, our study focuses
on the latter, and more specifically on its two dimensions and
their effects. Access to health information is indeed both about
literacy and knowledge that patients have access to, share and
contribute to producing, and also about the sociomaterial and
technological conditions for this discourse to emerge among
previously disconnected actors.
With the emergence of participatory medicine and patient-generated data (Topol, 2015), Web 2.0 technologies are
transforming the ways patients seek information and manage
their health by tracking and generating scientific health information in real time (Eysenbach, 2008; Hesse et al., 2010).
Hierarchies of knowledge production and dissemination have
started to become more leveled with increased access to
medical knowledge and services (Rier & Indyk, 2006), to ‘anyone who is curious, regardless of their training’ (Boyd &
Crawford, 2012, p. 664). As argued by a parallel and complementary study on PatientsLikeMe, ‘unconventional, Internetbased organizational forms address traditional expert problems
(medical research) through the systematic involvement of
non-professionals (patients)’ in ‘stark contrast to the complex,
expert-dominated, prestige-laden, and costly institutional arrangements characteristic of medical research’ (Kallinikos &
Tempini, 2014, p. 817; Tempini, 2015). The way this challenges
the power hierarchies in healthcare is changing what ‘research’
and medical knowledge generation mean.

Research context: PatientsLikeMe.com
PatientsLikeMe is a Medicine 2.0 platform described as a webbased service using social media technologies for social networking, participation, and collaboration among healthcare
actors (Eysenbach, 2008), connecting over 750,000 patients
suffering from severe and/or chronic illnesses and collecting
self-reported health data about over 2,800 conditions.1 These
data are compiled by PatientsLikeMe, and used for scientific
and commercial research.2 PatientsLikeMe was founded as a
Retrieved from http://www.patientslikeme.com/about
According to the latest available list (dated January 2019, Retrieved from
https://patientslikeme-bibliography.s3.amazonaws.com/PLM%20
Research%20Manuscripts%20Bibliography.pdf), PatientsLikeMe has participated in the production of 111 scientific publications.
1.
2.
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privately funded for-profit organization in 2004 by the
Heywood Brothers, after one of them was diagnosed with a
life-changing neuro-degenerative disease, amyotrophic lateral
sclerosis (ALS). It crowdsources patient care (Topol, 2014) and
is established as an opt-in service, not a healthcare provider, to
circumvent the Federal Health Insurance Portability and
Accountability Act of 1996 rules that control the flow of patient data in the USA.
At no monetary cost, PatientsLikeMe enables patients first
to manage their care by tracking their disease’s evolution
through their profiles and a variety of self-reporting and datafication tools, which was otherwise almost impossible to do
and comprehensively visualize by patients themselves3 (see
Kallinikos & Tempini, 2014; Tempini, 2015). PatientsLikeMe creates disease-specific communities and enables patients with
the same condition to share information and experiences with
other community members, as well as other external actors,
such as healthcare providers, pharmaceuticals, and the government. PatientsLikeMe aggregates this patient data (plus patient-reported measures on quality of life; forum discussions
and patient surveys) into a massive goldmine on drug side effects, and patient health and lifestyles. These patient-reported
data are continuously and systematically recorded, pooled and
shared with partners for medical research in anonymized aggregated form, and these partners also recruit PatientsLikeMe
patients for randomized clinical trials. PatientsLikeMe partners
with non-profit organizations and academic research institutions for free, and sells aggregate patient data to pharmaceutical companies – its only revenue-generating source. It foregoes
advertising to provide comfort for patients in sharing their
data, hence relying only on word-of-mouth sustainability.

Methodology
We conducted an extended observational netnography of
PatientsLikeMe (Caliandro & Gandini, 2017; Kozinets, 2010), a
methodology and design that are particularly rich for studying
online communities (Park et al., 2019). As healthcare can be
considered as a sensitive research topic, this allowed us to precisely follow naturally occurring dynamics of members (their
archival, live dialogues, and interactions through field-notes) in
an unobtrusive way, thus avoiding undesirable outsider effects
(Langer & Beckman, 2005).
We ensured trustworthiness in netnographic research
(Kozinets, 2010) through extended immersion, ongoing observation, and triangulation over a 2-year period. We complied
with ethical research standards, since, first, ‘the behavior being
observed is commonly performed in public […], and in a setting where the anonymity of the person being observed is
See, for instance, the profile and charts of Heywood (deceased in 2006),
made openly Retrieved from https://www.patientslikeme.com/members/40
3.
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assured’ (Zikmund & Babin, 2006, p. 242). Second, we collected
and analyzed the existing publicly available archival and observational data, and third, the researcher’s presence was fully disclosed while not interacting with members (Kozinets, 2010).
Anonymity is maintained to protect participants’ both real and
pseudo identities (Park et al., 2019).
Our netnographic data collection was conducted in four iterative steps. First, the decision to research PatientsLikeMe was
initially inspired by a cover story in Business 2.0 magazine
(Schonfeld & Morrison, 2007) that identified 10 exemplar organizations – including PatientsLikeMe – that had the potential
to rewrite the rules of existing industries and create new markets.We began by observing and learning about PatientsLikeMe
and its members, and why and how they interact with the
tracking technologies and other actors on the platform.
Second, we sought to develop a deep understanding of
what makes people share their sensitive private health and
lifestyle data (our exploratory question) and contribute to
medical knowledge production and distribution, and how this
process is organized on PatientsLikeMe. To do this, we registered with a guest account, which enables various researchers
to engage on this platform. We began our observations in the
public community blog, where there were ongoing high-traffic
discussions around privacy, data sharing and tracking, patient
empowerment, and big data use. We observed that the majority of the posts on these issues were from patients in multiple
sclerosis (MS) and Mood sub-communities, which then directed us to continue our investigation in the forums of these
sub-communities.
Third, we triangulated data from a variety of sources in multiple rounds, involving (1) archival data from news and articles
about PatientsLikeMe in business magazines (e.g., New York
Times, Business 2.0, Forbes, Economist, Wall Street Journal, and
BusinessWeek), the public community blog, YouTube videos,
published research by PatientsLikeMe and industry partners in
scientific journals; (2) field notes; and (3) textual data from
numerous member posts and their interactions in different
sub-communities and the community blog (see Table 1 for detailed information on data sources and use). Attention was
given to all exchanges in MS and Mood sub-communities (patient-to-patient, patient-to-administrators, researchers, and
founders’ interactions).
Fourth, our analysis (see the next section) used the keyword
method (keywords: disclosure, privacy, sharing, tracking tools,
openness, transparency, community, secrecy, monitoring, tracking,
big data, crowdsourcing, empowerment, Web 2.0, pharmaceutical, government) to go through the immense number of posts
(cf. Table 1). This was informed by our exploratory question on
private health data tracking and sharing (Kozinets, 2010). We
then realized that in the discussions and in the practices of sharing, tracking, and monitoring each other’s health, PatientsLikeMe
was actually fostering what appeared to be a complex
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surveillance network among multiple stakeholders. In our iterative analysis, we were increasingly directed toward surveillance
literature, which led us to progressively inductively study
PatientsLikeMe through this lens and ultimately as a surveillant
assemblage, as detailed in our analysis.

Data analysis
Observations and downloading of textual data were done over
2 years until saturation was reached (Glaser & Strauss, 1967),
with ongoing initial reflections by the first author. Subsequently,
together we iteratively proceeded to the initial data coding to
discover the main themes, particularly relevant for understanding the dynamic complexity of online interaction phenomena
(Caliandro & Gandini, 2017). Following the inductive coding
schema (Glaser & Strauss, 1967), we compared first-order
codes (informant-centric terms to define digitally mediated
practices and interactions on PatientsLikeMe) to clarify themes
through an inductive and recursive process and create second-order theory-laden constructs (Gioia et al., 2013).This process was performed individually, and then together, to establish
the credibility of codes discovered. In the open coding phase,
also known as the constant comparative method, we identified
two broad categories: how actors engaged on PatientsLikeMe
(through 15 digitally-mediated practices) and why (16 desired or
resulting outcomes of these practices), looking for emerging patterns as well as staying alert to irregularities. Once coded, we
realized that these broad categories were operating at micro-,
meso-, or macro-levels, which led us to group initial findings into
such levels for greater clarity and analytical purposes. Our final
data structure is summarized in Fig. 1.
While data privacy was one of the key issues being discussed by PatientsLikeMe users and that initially drove our attention to study this platform, our findings yielded intriguing
positions from the community members concerning how
tracking tools were being used for surveillance purposes on
various interrelated levels. Health data were being massively
recorded and shared, and arguments for such sharing outnumbered and outweighed privacy concerns, and a variety of
stakeholders were ‘converging’ on the platform.
This is when we realized that health-tracking tools were
used for surveillance purposes (e.g., patients surveilled their
health but also others’), and patients were not the sole targets of surveillance, which was also being directed to experts, and pharmaceutical companies (taking surveillance
beyond the platform). This intriguing observation made us
think of surveillance as a way to make sense of our data
(with five second-order codes to categorize the surveillance practices across micro-, meso- and macro-levels) and
tempted us to engage in a critical reading. However, the
more we immersed in it, and despite the iterative loops
with critical literature on the risks of pervasive surveillance
23
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Table 1. Data sources
Data type

Use in data analysis

PLM Archival Data

• Focus on doctor/researcher-patient, patient-patient, patient-PLM
community support team/founder, doctor/researcher-PLM founder/
community support team conversations and posts

• Raw data from discussion forums from MS subcommunity (2670-word
pages)
• Raw data from discussion forums from Mood subcommunity (1117word pages)
• Raw data from PLM community blog open to public (351-word pages)
• Patient profile data: (40-word pages)
• https://www.facebook.com/PatientsLikeMe
Total: around 7000 postings

• Understand what motivates/deters patients to join and share their data
on this platform, how they benefit from the data they provided, how use
these tools both inside and outside the platform
• Understand patient privacy concerns
• Understand the power dynamics in the community for sharing, gathering,
and organizing data
• Understand how patients benefit from the data they provided
• Understand the history of PLM and how it functions
• How patient data are used in research
• How disease tracking tools are developed

Secondary Data

• Learn about the history and origins of PLM platform and their mission

1) News data:

• Learn about the changing power dynamics in the healthcare industry and
scientific medical research process with participatory medicine

• Goetz, T. (2008, March 23). Practicing patients. The New York Times. https://
www.nytimes.com/2008/03/23/magazine/23patients-t.html
• Singer, N. (2010, May 29). When patients meet online: Are there side
effects? The New York Times. https://www.nytimes.com/2010/05/30/
business/30stream.html
• Schonfeld, E. & Morrison, C. (2007). The next disruptors: The 10 game
changing startups most likely to upend existing industries and spawn new
entrepreneurial opportunities. Business 2.0, 8(8), 56–64.
• Arnst, C. (2008, December 4). Health 2.0: Patients as partners. BusinessWeek.
https://www.bloomberg.com/news/articles/2008-12-03/health-2-dot-0patients-as-partners
• Inaugural JMIR Medicine 2.0® award goes to PatientsLikeMe researchers
(2009, August 25). Journal of Medical Internet Research. https://www.jmir.
org/announcements/27
• Heywood, J. (2009, May 20). Testimony of James Heywood co-founder
and chairman PatientsLikeMe Inc. before the national committee on vital
and health statistics subcommittee on privacy, confidentiality and security.
https://s3.amazonaws.com/patientslikeme_research/PLM_NCVHS_
Testimony.pdf
• Johnson, C. Y. (2008, November 6). Through website, patients creating their
own drug studies. Boston Globe. https://archive.boston.com/news/health/
articles/2008/11/16/through_website_patients_creating_own_drug_studies/
• Cohen, E. (2008). Patients find support, help via online networking. http://
edition.cnn.com/2008/HEALTH/10/09/ep.health.web.sites/index.html
• Eysenbach, G. (2008). Medicine 2.0: Social networking, collaboration,
participation, apomediation, and openness. Journal of Medical Internet
Research, 10(3), e22. doi:10.2196/jmir.1030
• Frost, J. H. & Massagli, M. P. (2008). Social uses of personal health
information within PatientsLikeMe, an online patient community: What
can happen when patients have access to one another’s data. Journal of
Medical Internet Research, 10(3), e15. doi:10.2196/jmir.1053
• Gill, M. (2019, September 2). Patient data for sale. British Medical Journal
Blog. https://blogs.bmj.com/bmj/2019/09/02/michael-gill-patient-data-for-sale/

• Understand the function of data intermediaries (such as PLM) in medical
research
• Learn about how patient data are used from research conducted in the
community by PLM research scientists
• Understand how patients inform medical practices through post-market
drug data
• Understand the platform’s stance on privacy and openness and how the
platform de/reconstructs these concepts.
• Understand how the user-generated medical knowledge challenges
scientific drug development
• Learn about different stakeholders involved in research on the platform
• Learn about how PLM promotes data sharing and openness in
healthcare
• Learn about the partnerships PLM develops in healthcare in order to
measure, prevent, predict, and treat diseases
• Understand the value of tracking patient data for the patient, the
government, and the pharmaceutical
• Understand why patients want healthcare industry engagement in
tracking patient data
• Understand how PLM involves industry partners in tracking patient data,
listening to patients and developing new disease measurement tools with
patients
• Understand the future of personalized medicine and drug discovery via
health platforms
• Find out what kind of data protection mechanisms PLM develops to
prevent data scraping and privacy issues
• Question the value and limits of patient generated data compared to
evidence-based scientific data
• Question the value and limits of scientific medical research process
• Understand how measurement (tracking) tools are developed

(Continued)
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Table 1. (Continued) Data sources
Data type

Use in data analysis

2) Video data on PLM:
• https://www.youtube.com/watch?v=2holmeyOd4E
• https://www.youtube.com/watch?v=8I9qHSi6s8I
• https://www.youtube.com/watch?v=kGcJLYZXz-E
• https://www.youtube.com/watch?v=PWKZ0RubCqs
• https://www.youtube.com/watch?v=xGnfWjUXf4g
• https://www.youtube.com/watch?v=viO5qnYx7Rc
• https://www.youtube.com/watch?v=GFO16TAC7XY
• https://www.youtube.com/watch?v=TNl3p3jKvow
• https://www.youtube.com/user/PatientsLikeMe2008/videos
• https://www.youtube.com/watch?v=mRJXrpEiW7U
• https://www.ted.com/talks/jamie_heywood_the_big_idea_my_brother_inspired
• https://www.youtube.com/watch?v=tLlF3pvbJZg
• https://www.youtube.com/watch?v=XQZ5M9oLkXw
• https://www.youtube.com/watch?v=dVBrWmA52J4
• https://www.youtube.com/watch?v=wch3GdWJiLc
• https://www.youtube.com/watch?v=E_mgOPzgmU4
• https://www.youtube.com/watch?v=C88xC0mc0bY
• https://www.youtube.com/watch?v=yt0rUz64wpE
• https://www.youtube.com/watch?v=pTuemJ7ISaM
• https://www.youtube.com/watch?v=BXteuq01AqI
• https://www.youtube.com/watch?v=adwHhBRghzM
• https://www.youtube.com/watch?v=d-uC0B7YWdQ
Field notes from non-participatory observations
• Notes taken during patient-patient, patient-doctor, patient-researcher,
patient-PLM founder, patient-PLM community support team interactions
from MS and Mood subcommunities

in the digital age, we realized it would be imposing a reading
that did not quite fit. We agreed that the themes that
emerged were telling a different story, pointing toward
other outcomes than capitalistic exploitation. We identified
two second-order codes to categorize such outcomes: patient empowerment and multi-stakeholder engagement in
medical knowledge generation, indeed, challenging traditional power hierarchies in healthcare.
At that point, we moved to the axial or conceptual coding
and returned abductively to the literature calling for more
attention being paid to other more ‘positive’ outcomes of
surveillance, and particularly Haggerty and Ericson’s (2000)
notion of surveillant assemblage that could account for the
converging flows of surveillance in and through PatientsLikeMe.
We finally made relational connections within the data structure more salient (Gioia et al., 2013) with second-order constructs pertaining to two derived theoretical dimensions: (1)
multi-level flows of surveillance and (2) desires that ‘hold
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• Understand the power dynamics among stakeholders for sharing and
producing health data and patient-led medical research
• Understand the opportunities and challenges associated with tracking
patient data

together’ the surveillant assemblage, each spread out across
micro-, meso- and macro-levels (summarized in Fig. 2).
In the next section, we unpack our findings using selected
quotes from the various data sources that triggered and illustrate each theme.

Findings: PatientsLikeMe’s surveillant
assemblage
Through this study, we identified that each actor had particular
expectations or desired outcomes, which motivated the kinds
of surveillance practices they engaged in. Ultimately, these
practices unravelled at micro-, meso-, and macro-interrelated
levels in and through the platform, making PatientsLikeMe the
locus where such multi-level flows of surveillance converged
and ‘worked together’, thereby constituting a surveillant assemblage, summarized in the form of a funnel in Fig. 2, and
unpacked next.
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First-order codes

Second-order constructs

• Patient data tracking by physician on the platform
• Doctor visit sheets enabling centralization of patient data and mediating
patient physician relations in and outside the platform
• Normalization of data sharing (promoting sharing as a human
right, de-identification, transparency)
Pharmaceutical and research institutions
• Track and recruit patients for clinical trials
• Analyze patient led data to validate clinical research and inform their clinical trial
protocol design
• Discover secondary uses of medications via patient-generated data
• Test validity of new tracking tools to monitor patient data via patient collaboration
State agencies
• Patient direct reporting of drug side effect data to FDA via the platform
• Alternative pharmacovigilance via patient reported data to monitor drug safety
after-market release
• Inform patients about the ongoing active randomized clinical trials, for
which they may be eligible

Self-surveillance

• Patient engagement in designing more inclusive tracking tools
• Patient impact on scientific medical knowledge generation
• Easy and cheap/free access to patient-generated data
• State oversight of the healthcare market

Micro level
Meso level

• Legitimizing the platform organization as a data intermediary in healthcare
• From proprietorship to partnership in medical data sharing and distribution

Surveillance
in platforms as a
surveillant assemblage

Intra-surveillance

Inter-surveillance

Multi-level flows of
surveillance

Corporate &
Institutional
Surveillance

Patient
empowerment

• Sharing information and experiences
• Caring for the self and the other
• Improved communication between patient and doctor in clinical setting
• Centralizing patient data to improve data flow among healthcare providers and
personalized medicine

Derived
theoretical dimensions

State Surveillance

Macro level

Desired outcomes

• Increasing awareness of embodied self
• Disease literacy
• Increased access to clinical trials
• Promote for funding and faster discovery of ailments
• Personalized medicine
• Making diseases more visible and human

Macro level

Digitally-mediated practices in and through PLM

• Monitoring and increased awareness of other’s well-being via tracking tools
• Patient responsibilization via tracking tools
to reorganize their roles and
identities in relational exchanges
• Patient responsibilization in data sharing via light touch moderation

Meso level

Micro level

• Monitor one’s disease progression and treatment via tracking tools
• Patient sharing of personal experience and health data

Desires that
‘hold together’
the surveillant
assemblage
Multi-stakeholder
engagement in
medical knowledge
generation

Figure 1. Data Structure

Micro-level
Self-surveillance
Actors reorganize their roles and identities as dividuals (in particular, patients) through interactions with tracking tools on the
platform. In their profiles, patients objectify themselves by listing symptoms via disease-specific and general tracking technologies, treatments received, and different lifestyles led. For
example, epilepsy patients use a weekly tool called the ‘seizure
meter’ to track the type, frequency, and severity of their seizures and code their symptom data in a structured format.
Such tools are developed and continuously updated via patient
input, thus enabling patients to closely monitor their own condition and even discover new conditions, the outcome of
which is more self-awareness and disease literacy:
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I’ve gained a lot of insight from mood tracking tools, seeing patterns
in my mood cycles and how that relates to factors like medication
changes and weight gain. (Patient59, Mood)
Over the years I’ve had bouts of depression which I’ve added to my
Mood Map…Then – whoa – in looking over the chart I realized that
the bigger issue in my life has been compulsion…Having identified
this I can now wrestle with how to live with it. (Pat62, Mood)

In conventional surveillance, individuals lacked self-understanding, while information retention by the medical elite was
somehow justified as ‘for their own good’ (Foucault, 1975).
These self-surveillance practices are what PatientsLikeMe was
primarily built for, and in seeking to increase awareness of their
embodied self and disease literacy, they engage in self-datafication. This allows them to visibilize their disease and themselves:
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MS is not a dirty secret for me. It’s a tiny part of who I am…I will not
keep it a secret, and giving a face to MS makes it more personal and
human to others. (Patient66, MS)
The more I talk about living with HIV, the easier it becomes to actually live
with it. It also gives me a chance to put a face to the disease, humanizing
it and hopefully dispelling some ignorance and fear. (Patient67, HIV)

Data sharing increases both individual and public literacy
about diseases, which humanizes and makes them more ‘livable’.
Intra-surveillance
PatientsLikeMe patients also desire to find others suffering
from the same condition in disease-specific communities as its
name suggests, and constitute support groups to generate and
share data, aided by visualization tools once more:
We’re just aware of each other’s moods more on here through mood
charts and can empathize with each other more. (Patient61, Mood)

Our analysis of video data also reveals that search tools and
disease symptom charts enable patient analysis of disease data
via matching algorithms to compare with other patients’ personal
profiles and personalize his or her treatments accordingly. (https://
www.youtube.com/watch?v=wch3GdWJiLc). The platform also
licenses patient reported outcome measures under creative
commons open for all to share and suggest improvements for a
personalized treatment protocol, including drug and supplement
use, lifestyle and dietary changes, and communicating disease-specific data (https://www.youtube.com/watch?v=XQZ5M9oLkXw).
However, gazing on others’ profiles not only enhances disease
literacy and better knowledge of the self through exchanging
with peers but also triggers forms of empathic oversight:
We had a patient whose weight was dropping precipitously, which can
accelerate a patient’s deterioration in ALS. Since patients track and share
their important outcome measures, another patient could remind him of
the importance of keeping his weight up. (Founder1, Community blog)
Everyone snarling back at her is NOT going to help. Anybody looked
at her mood map? Depression almost off the chart, same with
compulsion. She is having a BAD TIME, people… (…) Doesn’t that
suggest that we should be rallying around her to support her, instead of
further tearing her down??? (Patient 63, Mood)

This empathy is further sustained by self-modulation and responsibilization to enable a smooth flow of data sharing. Dialogues
between patients and staff reveal this responsibilization as patients
watch over each other, and endow community members with a
licence to surveil and police in order to protect:
Our community members are a very switched-on group. If anybody
posts something suspicious or overtly commercial we normally hear
about it in a matter of minutes and can respond appropriately.
(SupportStaff3, Mood)
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Our observations of forum discussions also suggest that
light-touch moderation discourse facilitates surveillance by
pushing patients to share and update as much data as possible
on their profiles in an effort to increase the authenticity of
their profiles and data harmonization:
Patients who (…) sort of have an aggressive voice on the forum,
who don’t fill out their profile tend to get pushed by others in the
community to do that, because it becomes a validator of who they
are, which is an incredibly powerful part of our model. (Founder1,
Mood)

Sometimes, such responsibilization backfires, for example,
when dealing with trolls or those who create chaos in the
community and obstruct data generation. In such cases,
PatientsLikeMe staff interferes and controls the situation for a
continuous and smooth data generation, and creates a forum
code of conduct. Overall, this also helps those new to the
platform to feel confident enough to interact, being welcomed
by older community members.
To sum up, by engaging in self- and intra-surveillance, knowledge and caring function in an intricate way with potentially
vital consequences:
This is where I come instead of self-harming or attempting suicide. The
highlight of every third day is that I get to do my mood map, which
stops me from putting myself in hospital. (Patient94, Mood)

Self- and intra-surveillance on PatientsLikeMe overcome the
prior disconnection between patients in the traditional health
system and yield betterment of social relations, where patients
aim for self-datafication and personalization while engaging in
caring surveillance relationships.

Meso-level
Inter-surveillance
Surveillance practices also extended beyond the platform
through its network of stakeholders, thereby challenging the
existing meso-level interactions. PatientsLikeMe engages physicians through clinical research and using the platform as a way
of tracking patients between visits. Patients also bring ‘doctor
visit sheets’ designed for tracking their condition during their
doctors’ appointments, which destabilize traditional relational
power dynamics:
Drugs I’m currently on were never offered to me during my six years
with MS, due to my inability to adequately describe my symptoms,
and my doctor’s inability to think outside the box from what he
defaulted to using. Through doctor visit sheets, I learned to describe
my symptoms better, and shared with my doctor other treatments.
With a little time, he became more open, and I communicated better.
(Patient23, MS)
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In the past, we physicians had information power and (since it dictated
our livelihood) we guarded it jealously. Patients didn’t have the ability
(or desire) to read through complex medical texts to understand their
diagnoses. Now, they routinely come to me armed with a printout from
WebMd or PatientsLikeMe and more often than not they are spot
on. As a physician, I am no longer one who hoards information but a
consultant who provides experience, context, meaning and perspective
to what the patient is experiencing. (Physician1, Community blog)

Some physicians in PatientsLikeMe now praise self-tracking
tools and the resulting patient-generated data, perceived as a
sign of increased patient literacy and an opportunity to collaborate with them in clinical settings. This enhances inter-surveillance dynamics by carrying the flows of surveillance
beyond the patient community and the platform. This is motivated by the desire of more personalized medicine and reducing medical errors. Patients can compare their physician’s
decisions against their medical history recorded via tracking
tools on PatientsLikeMe, which enables a smoother patient
data flow and improved connection among healthcare
providers:
Almost every time I’ve been hospitalized, I’ve been thrown in with an
unfamiliar psychiatrist who gives me a new diagnosis and a completely
different set of medications. …I now keep a centralized record of my
mood and treatment history via mood charts and doctor visit sheets on
PatientsLikeMe, which I use as a reference and share with treatment
providers. (Patient37, Mood)

While concerns regarding personalization through surveillance
practices remain, self-reflexive accounts signal both the awareness
of these issues and the mitigating role of the platform:
I think some patients may be their own worst enemy. For instance,
doctor visit sheet and mood charts. I try very hard to be completely
honest as I answer the survey questions, but I can easily see how I can
manipulate the results to convince my doctor to prescribe me certain
meds or diagnose me with something I may feel more comfortable with.
Sometimes knowing you are being scrutinized, and specifically what about
you is being scrutinized can affect your behavior. (Patient97, Mood)

In destabilizing meso-level interactions in healthcare,
PatientsLikeMe challenges the current constitution of privacy
by making patient engagement in surveillance and sharing of
private health data acceptable through framing data sharing as
a ‘human right’ and normalizing discourses, such as transparency and de-identification. Furthermore, in carrying the flows
of surveillance to clinical settings PatientsLikeMe promotes a
transformation from proprietorship to partnership in disclosure and distribution of medical data, which challenges the
very definition of privacy, that is, control over externalization of
one’s personal information, which belongs to the person
(Goodwin, 1991). For example, PatientsLikeMe co-authored
the Declaration of Health Data Rights and launching
HealthDataRights.org in June 2009. The founders of
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PatientsLikeMe also testified before the National Committee
for Health and Vital Statistics at the Gov 2.0 Summit to challenge the reliance of macro institutions on secrecy and desire
to have control over private information:
A modern focus on privacy as a goal has moved the line to the point
that medicine is slowed, treatments are delayed, and patients die for
failure to have what they need when they need it. We have substituted
real harm for mostly theoretical harm. We believe that openness is
much more powerful concept than privacy in medicine, and one that
gives patients the power to take control of their health. (Founder1,
Community blog)

The founders of PatientsLikeMe challenge the dynamics of
the current healthcare market that functions on privacy as an
absolute goal and a fundamental human right, a right to ‘not
share’. Openness and transparency promoted as core organizational values work through people’s desires to improve and
manage their care, while making data anonymous provides feelings of safety for normalizing surveillance at the meso-level.

Macro-level
Corporate and institutional surveillance
Other healthcare stakeholders, such as pharmaceutical companies and research institutions, are also involved in surveillance relationships in PatientsLikeMe. Data collected using
tracking technologies are shared with them to bridge the gap
between anecdote and evidence-based medicine, to inform
and guide future clinical practice. This translates into pharmaceutical companies tracking PatientsLikeMe patients for research (e.g., Genentech was granted access to PatientsLikeMe
data to study drug effectiveness for cancer treatment); recruiting patients for randomized clinical trials (e.g., Novartis
has recruited PatientsLikeMe MS patients); and analyzing existing PatientsLikeMe patient-led clinical research to validate
their own research, test or generate hypothesis, and inform
their clinical trial protocol design. This aims to provide alternative solutions to existing ailments and improve existing
solutions in a timely manner, as reflected in our analysis of
news items and published medical research using
PatientsLikeMe data. For example, PatientsLikeMe research
scientists won the 2009 Journal of Medical Internet Research
Medicine 2.0 Award for research on secondary uses of drugs
or drugs that are off-patent and unlikely to be studied systematically. This enables pharmaceutical companies to have
easy and inexpensive access to patient-generated data, potentially lower research costs and faster clinical research processes that provide real-time feedback from patients (cf.
Arnst, 2008 in Table 1).
Despite some data scraping incidents on the platform
(Angwin & Stecklow, 2010) (our video data also suggest that
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PatientsLikeMe creates a contractual relation with industry partners in order not to reidentify or scrape data, which will have
legal consequences [https://www.youtube.com/watch?v=pTuemJ7ISaM]), patients actually endorse the use of PatientsLikeMe
data for improved patient care:
We give Pharma real life experiences with medications they provide for
us, and make them better with less side effects. (Patient 103, Mood)
Data collection is what helps us get drug firms pay attention to what
works or does not work for MS. (Patient 104, MS)

Including corporate and institutional research partners in
the surveillant assemblage has several outcomes. Traditionally,
clinical trials have been dominated by medical authorities and
academics, which resulted in information sequestration, privileging the medical elite (Epstein, 2007). Although expert-collected clinical data and patient-generated data may sometimes
contradict due to methods and sampling (Kitchin, 2015), such
discrepancies provide useful information as well, and on the
whole, this collaboration is destabilizing the disciplining rules or
criteria of top-down medicine. One of the examples include
PatientsLikeMe’s MS rating scale, designed to exhibit symptom
data in the patient’s own language, which is made in collaboration with pharmaceutical companies and specialized healthcare
providers to test the validity of these tools (see Kallinikos &
Tempini, 2014):
If there are inaccuracies, we can modify the tool. We did this in
ALS community where one member indicated that ALS rating scale
didn’t pick up her changes having progressed to a very advanced
stage of disability. An extension was designed to pick up on changes.
(SupportStaff2, MS)

This tracking tool developed with patient input was validated by comparing the results with findings generated using
standard clinical assessment methods employed in MS (Bove
et al., 2013). PatientsLikeMe also launched the Open Research
Exchange hub to establish a collaboration ecosystem of industry partners and patients, thereby changing the way medical
knowledge is generated.
Another important outcome is that access, an important
challenge for big data, as it is privately produced, is overcome
to a greater extent (Kitchin, 2015).The PatientsLikeMeListen
service enables industrial partners to receive patient-repor ted outcome data via tracking tools on drug effectiveness and side-effect information. PatientsLikeMe also
performs sentiment analyses of patient discussions on drug
effectiveness in community forums, and enables pharmaceutical access to aggregated sentiment data. Along with
scientific exper tise, patient experiential expertise has the
potential to become a productive force in medical
research.
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State surveillance
By including State agencies in its web of interrelated
actors, PatientsLikeMe contributes to change our
traditional understanding of State surveillance and regulation in two ways: first, by inver ting the surveillant gaze.
Instead of monitoring patients with the aim of controling
them as in a Foucaldian scenario, PatientsLikeMe provides
a way for enhancing state oversight over pharmaceutical
companies by taking post-market surveillance (aka pharmacovigilance) to monitor drug safety after-market release,4 a step fur ther. Since 2008, PatientsLikeMe developed
a par tnership with the Food and Drug Administration
(FDA) and its MedWatch pharmacovigilance system5 to
self-generate, record, and track individual repor ts, and aggregate data from the patient community to share with
the FDA:
Patients desperately need a way to collect reports of adverse
effects from medications, a responsibility shirked by the FDA and
subverted by the drug companies. (Patient16, MS)
We launched a pilot program in our MS community, which helps
patients submit treatment related adverse events directly to FDA
through PatientsLikeMe. Understanding when these events occur
helps FDA better regulate pharmaceutical and medical industries
to protect consumer safety and bring safer, more effective products.
(Founder2, MS)

State collaboration with social media platforms and the use
of patient-generated data on these platforms for pharmacovigilance are a fairly recent phenomenon, as the State focuses on
patient’s voice for complementing the existing pharmacovigilance has been very limited (https://www.centerwatch.com/
articles/16413). By connecting the patient directly to FDA to
report drug side effects, PatientsLikeMe increases the responsibility of the State to further regulate the pharmaceutical industry (e.g., issue product recalls, warnings, and safety messages)
and compare patient-reported adverse effects with those of
clinicians in randomized clinical trials to assess the risks and
benefits of these reports. Such macro-level responsibilization
reduces the intrusion of pharmaceutical industry and influences how people evaluate and communicate the risks of existing medications (Cox et al., 2010).
Second, PatientsLikeMe provides information to patients regarding state health-related initiatives. For instance,
PatientsLikeMe imports data from a federal site called clinicaltrials.gov (where all US clinical trials are required to register) to
In the USA, this is led by the FDA, usually performed via clinical trials with
small numbers of patients in controlled circumstances.
5.
MedWatch is FDA’s voluntary drug adverse event reporting system
largely used by healthcare providers and inaccessible to patients until the
partnership.
4.
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inform patients about the ongoing active randomized clinical
trials, for which they may be eligible. Other collaborations, for
example, between the US Department of Veterans Affairs’
Epilepsy Centers of Excellence, PatientsLikeMe, and UCB
Pharmaceuticals for research into the factors that influence
health outcomes for veterans with epilepsy, bring State bodies
into the surveillant assemblage.
Overall, multiple stakeholder engagement in organizing big
data generation via surveillance practices in and through
PatientsLikeMe indicates that surveillance in platforms is not a
unilateral or top-down process but a multi-level flow of interrelated agencies and practices that ‘work together’ and are ‘held
together’ by the outcomes desired by each party. All the stakeholders involved become knowingly both the agents and the
targets of surveillance converging in a co-constructed and surveilled digital environment, and it is these practices that constitute PatientsLikeMe as a multi-level surveillant assemblage.

Discussion

• Patients
• Physicians
• Caregivers
• Researchers
• PLM staff
• Research institutions
• Pharmaceutical
companies
• State agencies
• Tracking and
measurement
tools and algorithms
• Data aggregation and
reporting processes
• Data communication
processes
• Clinical trial processes…

PatientsLikeMe

Multiple objects in flow

This study shifted analytical attention to aspects of surveillance
often left understudied: what kind of surveillance practices
emerge in and through platforms, which stakeholders are involved, and what outcomes are produced? By exploring how
‘individuals actively participate (wittingly or not) in their own
visibility, thereby creating new potentialities of surveillance by
others’ (Brivot & Gendron, 2011, p. 140), we raise a scantly
studied question on what happens when those who were

Digitally-mediated
surveillance
practices
via the platform

once under surveillance, and thereby disciplined and controlled, now enact surveillance themselves. Concretely, we
were able to highlight how surveillance operates at multiple
inter-related levels that are ‘knotted together’, that is, converging on the platform. This provides two main contributions and
several potential directions for future research studies.

Platforms as loci where multi-level surveillance
phenomena converge
First, we show how platforms serve as digitally mediated
spaces for surveillance, constituting a dynamic crossroads of
micro-, meso- and macro-surveillance phenomena both within
their online communities and beyond. Unpacking the multilevel complexity of surveillance in and through platforms reveals how such levels, practices, and objects are held together
in a digital environment, converging as a surveillant assemblage
(Haggerty & Ericson, 2000). Figure 2 provides a visual representation of this convergence in the form of a funnel, illustrating multiple objects in flow (information, bodies, desires,
institutions, and processes), making several systems, directions,
outcomes, and levels of surveillance converge into a functional
entity that transforms the purposes and hierarchies of surveillance. Our case reveals platforms’ potential for fostering and
shaping a complex web of such surveillance flows, how and
why all these converge and ‘work’ together and constitute a
surveillant assemblage.

Multi-level surveillance flows
converging on the platform
• Self-surveillance
• Intra-surveillance
• Inter-surveillance
• Corporate and Institutional surveillance
• State surveillance

Patient empowerment
Multi-stakeholder
engagement in
medical knowledge
generation

Figure 2. Multi-level Surveillant Assemblage
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This conceptualization can revitalize the study of surveillance in and through platforms by allowing a more fine-grained
analysis of its complex, rhizomatic, and multi-level dimensions.
It could also complement sociomaterial accounts of platforms
(Orlikowski & Scott, 2014) with whom surveillance studies
share the notion of ‘assemblage’. However, Deleuze and
Guattari, whose work Haggerty and Ericson relied on to theorize surveillant assemblages, use the French word agencement,
which translates into English as ‘assemblage’. This nevertheless
neglects a key dimension in Deleuze and Guattari’s thinking
rooted in its Latin origin: agens, that is, its agentic, dynamic, and
processual dimension, somewhat present in Haggerty and
Ericson’s notion of ‘desires’ that make the systems converge,
but not as salient as in Deleuze and Guattari. This is of prime
importance in sociomaterial studies of information technology
(Cecez-Kecmanovic et al., 2014) and in studies of the role of
human and non-human actors and interactions (Taupin, 2019)
in yielding social and institutional change and alternative forms
of organizing (Ouahab & Maclouf, 2019). This essential point
should make us further refine our understanding of the surveillant assemblage not only as a sociomaterial assemblage of
surveillance flows but also as an agencement process that sets
such flows in motion and makes them converge and produce
or perform particular outcomes – a key question for future
studies to explore.

Potentialities of the platforms’ surveillant
assemblage
Second, our study answers call to go beyond the risks of platform-related surveillance (e.g., Albrechtslund, 2008; Hafermalz,
2020; Lyon, 1994, 2007; Pridmore, 2013). Within the surveillant
assemblage of PatientsLikeMe, surveillance becomes more relational and entangled than ever and seems to be empowering
patients’ license to heal by shifting traditional power dynamics
(Haggerty, 2006) in healthcare. Data sharing and aggregation
enable new forms of patient empowerment and knowledge
generation, ultimately influencing patient well-being, transforming roles, hierarchies of visibility and power, and relations
among stakeholders in and beyond the platform. Our netnographic design is part of the novelty of our study of surveillance in platforms inclusive of elements relevant to the
experience of surveillance on the receiving end (Hafermalz,
2020). Our study findings hint toward the potentialities of surveillance no longer being just an omniscient exploitative practice exerting control over populations (Zuboff, 2015, 2019).
Such risks do not disappear, but are subsumed into a more
complex process where it is not so easy to either fully accuse
or praise platforms’ surveillance effects.
This highlights not only constraining but also enabling power
dynamics on healthcare platforms. The question of access to
health, being mediated by technology, has been criticized for
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stressing inequalities (Fotaki, 2009; Visser et al., 2019). However,
PatientsLikeMe, while being fundamentally a platform of patients,
brings an understanding of individual patients not as consumers
of healthcare (as it does not offer healthcare services) but as a
networking platform of multiple stakeholders. Gaining literacy
and managing one’s disease fit a prosumer narrative but is sustained by a different ideology: ‘sharing as a fundamental human
right’.There is, indeed, no such thing as a ‘universal patient’ (Visser
et al., 2019), and PatientsLikeMe precisely seeks to harbor a myriad of different patient experiences, whose multiplicity should be
made visible by the platform. This brings attention to ‘why individuals take on the responsibility of ‘visibilizing’ themselves, (…)
due to an existential need to be seen as a legitimate member
(…) to remain ‘on the inside’’ (Hafermalz, 2020, p. 7) and not be
cast out of society due to their disease.
Through the surveillant assemblage, all involved actors
knowingly become both the agents and the targets of surveillance, which is not fixed or unilaterally given by the technological environment but is enacted in practice. Patients engage in
self-datafication that enables increasing caring and awareness
of the self and others. Decisions people make concerning their
care become more reflexive and confident, which then allows
them to make more direct and deliberate demands from
other entities on and beyond the platform. We find that both
state and non-state actors, private actors, and communities
gain relative power to perform surveillance activities, and
greater control over being surveilled voluntarily. For patients,
such voluntary visibilization of oneself is often framed as a reflexive, relational, and existential necessity (Hafermalz, 2020)
to connect with others (Iedema & Rhodes, 2010). For instance,
practices were shifting previous conceptualizations of privacy
and surveillance, and challenging their oppositional constitution. As already foreseen by Haggerty and Ericson (2000,
p. 616), ‘privacy is now less a line in the sand beyond which
transgression is not permitted, than a shifting space of negotiation where privacy is traded for products, better services or
special deals’. Concerns about privacy were omnipresent, and
understandably so; however, discourses about privacy on
PatientsLikeMe were contrary to what we expected: such
practices and their outcomes seemed to challenge the ‘inhouse assumptions’ (Alvesson & Sandberg, 2011) dominating
the literature on surveillance in platforms, which did not easily
recognize the potentials for new developments.
In less than two decades, platforms have achieved the prediction that Haggerty and Ericson (2000) had concluded
their study with: the ‘disappearance of disappearance’ in surveillance capitalism’s total reach, ‘making the Panopticon
seem prosaic’ (Galič et al., 2017, p. 25). However, even though
the platforms’ rhetoric may constitute an order through
which patient engagement in surveillance practices might be
tailored to corporations’ self-interests (Rose, 1999), patients
did not unilaterally equate to naïve dopes subjected to the
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exploitative gaze of surveillance capitalism (Zuboff, 2019)
and did not seem to engage with PatientsLikeMe in a consumerist fashion, contrary to what other recent works on
healthcare technologies have denounced (see Visser et al.,
2019). PatientsLikeMe patients, who perceive benefits to self
and others, and who feel ‘in charge’ of their data, tend to
choose data sharing over privacy, and opt for personalization
via collaborative modes of surveillance facilitated by new
technologies (Topol, 2014). Hence, a communitarian perception of privacy as a shared liability based on crafting a balance
between secrecy of individual information and responsibility
for aiding common good prevails (Etzioni, 1999).
Overall, the effects of and responses to surveillance invite us
to think beyond binary and reactive responses to surveillance,
and answer calls for a more encompassing view of surveillance
as it unfolds in platform organizations (Majchrzak et al., 2013).
One of the notable effects in this view of surveillance is responsibilization. To generate medical knowledge and effectively
contribute to levelling the power dynamics in healthcare, surveillance in and through platforms warrants a coordinated approach and responsibilization (Shamir, 2008) at all ends of the
spectrum, not only the neoliberal responsibilization of patients.
The macro-level for data security and management of surveillance on one hand, and at the micro-level of patients on the
other, as the sustainability of the system relies on patient literacy and expertise on providing their data and updating it regularly. Data (il)literacy remains an important struggle, as it may
obstruct decisions concerning patient care and scientific
knowledge production, as well as power dynamics, as disaccord may occur between patients and physicians in terms of
the standards used in surveillance tools to track patient health
(Bove et al., 2013). Another effect is personalization, which
poses ambiguities in terms of data manipulation and discrimination that potentially risk patient care and transparency in
patient–physician collaboration. While personalized medicine
via platform surveillance is in its early stages, for it to work efficiently, the vast amount of de-identified data will require the
necessary infrastructure, expertise, and systematic validation
from involved parties and tools (Topol, 2014) in order to analyze and make sense of it, and allow patient control in enabling
access to their specific health data that could cause stigma and
discrimination in managing patient care, but in ‘a double movement of autonomization and responsibilization’ (Rose, 1999, p.
174; Shamir, 2008).
Overall, our findings point to the empowerment of patients
and the inclusion of multiple stakeholders in medical knowledge
generation through convergent surveillance practices in and beyond platforms. This moves the traditional loci of patient and
disease tracking (from hospitals, laboratories, and doctors’ offices) toward a personal and collective setting, which challenge
the existing scientific research infrastructure and epistemological
expert-based tradition of medical research (Kallinikos & Tempini,
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2014). Although we find that PatientsLikeMe offers a great potential for patients to become literate in understanding and analyzing their illnesses, whether and how much this potential will
be realized and what conditions are required for this realization
are significant future research questions in PatientsLikeMe and
other platforms. For instance, designing platforms in ways that
promote literacy (Firat & Vicdan, 2008) and increased inclusion
of patients in the design of surveillance tools, the constitution of
surveillance practices, and oversight on the disclosure and sharing of the data will be essential. Although platforms harbor the
potential for increasing the scope and directionality of surveillance, avoiding some of the discriminatory effects of surveillance
requires constant vigilance by all stakeholders, including governments, advocacy groups, companies, and citizens, and granting
control of information flow among data partners to data subjects (Lyon, 2002).

Concluding remarks
As we witness the global reach of COVID-19 pandemic, we
realize the astounding contemporary relevance of how ‘surveillance is driven by the desire to bring systems together, to
combine practices and technologies and integrate them into a
larger whole (…) providing for exponential increases in the
degree of surveillance capacity’ (Haggerty & Ericson, 2000, p.
210). In early April 2020, a dedicated forum in PatientsLikeMe
included over 70,000 members and a very active Twitter account, where patients and health providers interacted to clarify
questions about this outbreak, filling and refining the Covid
symptoms tracker, and reporting and comparing treatments
received. Such initiatives based on citizen-generated data (e.g.,
eu-citizen.science) are burgeoning worldwide as a possible response to fast-evolving global sanitary crises for early detection (cf. Joshi et al., 2020) and monitoring the virus spreading
(Knight, 2020). This is providing a contemporary macro-justification of the openness philosophy of sharing micro-health
data defended by PatientsLikeMe and others, and is something
that each individual can contribute to while still complying with
lockdown measures. However, this only seems possible through
particular surveillant assemblages like we have described in this
analysis, where flows of information on a variety of surveillance
systems converge, geared at producing and distributing knowledge, while still remaining alert to potential manipulations and
requiring new responsibilizations, as future research might continue to explore.
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